Abstract:Infection of pregnant women by Zika virus (ZIKV) is associated with severe neurodevelopmental defects in newborns through poorly defined mechanisms. Here, we established a zebrafish in vivo model of ZIKV infection to circumvent limitations of existing mammalian models. Leveraging the unique tractability of this system, we gained unprecedented access to the ZIKV-infected brain at early developmental stages. The infection of zebrafish larvae with ZIKV phenocopied the disease in mammals including a reduced head area and neural progenitor cells (NPC) infection and depletion. Moreover, transcriptomic analyses of NPCs isolated from ZIKV-infected embryos revealed a distinct dysregulation of genes involved in survival and neuronal differentiation, including downregulation of the expression of the glutamate transporter vglut1 , resulting in an altered glutamatergic network in the brain. Mechanistically, ectopic expression of ZIKV protein NS4A in the larvae recapitulated the morphological defects observed in infected animals, identifying NS4A as a key determinant of neurovirulence and a promising antiviral target for developing therapies. Infections with Zika virus (ZIKV) constitute a major global public health concern worldwide. Indeed, infection of pregnant women can induce severe defects of the fetal brain and, eventually, microcephaly in the infant. Most importantly, no antiviral therapies or vaccines against ZIKV are currently available, as we poorly understand how the disease develops. Addressing these questions in mammalian models is highly challenging. Here, we report an alternative in vivo model of ZIKV infection based on zebrafish which circumvents limitations of existing models. Leveraging the unique tractability of this system, we gained unprecedented access to the ZIKV-infected brain during early developmental stages at the tissue, cell and molecular levels. The infection of zebrafish larvae with ZIKV phenocopied the disease in mammals including, a reduced head area and neural progenitor cells (NPC) infection and depletion. This correlated with a transcriptomic reprogramming of NPCs and alterations of the excitatory glutamatergic neuronal networks. Furthermore, we identified ZIKV NS4A as a key determinant of neuropathogenesis, supporting that this viral protein constitutes a promising antiviral target for developing therapies.

Sevsrvg Selectively Delivers Antiviral Sirna to Fetus Brain, Inhibits ZIKV Infection and Mitigates ZIKV-induced Microcephaly in Mouse Model

Zika Virus Propagation and Release in Human Fetal Astrocytes Can Be Suppressed by Neutral Sphingomyelinase-2 Inhibitor GW4869

EVs Containing Host Restriction Factor IFITM3 Inhibited ZIKV Infection of Fetuses in Pregnant Mice Through Trans-placenta Delivery.

A Peptide-Based Viral Inactivator Inhibits Zika Virus Infection in Pregnant Mice and Fetuses.

Disruption of Glial Cell Development by Zika Virus Contributes to Severe Microcephalic Newborn Mice

A Biomimetic Nanodecoy Traps Zika Virus to Prevent Viral Infection and Fetal Microcephaly Development.

A Single Injection of Human Neutralizing Antibody Protects Against Zika Virus Infection and Microcephaly in Developing Mouse Embryos.

miRNA-431-5p enriched in EVs derived from IFN-β stimulated MSCs potently inhibited ZIKV through CD95 downregulation

Vertical Transmission of the Zika Virus Causes Neurological Disorders in Mouse Offspring

Protocol for in utero injection to investigate Zika virus-related fetal microcephaly in mice

Cathelicidin-Derived Antimicrobial Peptides Inhibit Zika Virus Through Direct Inactivation and Interferon Pathway.

Identification of desoxyrhapontigenin as a novel antiviral agent against congenital Zika virus infection

Zika virus infection induces RNAi-mediated antiviral immunity in human neural progenitors and brain organoids

Fetal MAVS and type I IFN signaling pathways control ZIKV infection in the placenta and maternal decidua

Chloroquine Inhibits Endosomal Viral RNA Release and Autophagy-Dependent Viral Replication and Effectively Prevents Maternal to Fetal Transmission of Zika Virus.

Zika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent mice

Broadly Active Antiviral Compounds Disturb Zika Virus Progeny Release Rescuing Virus-Induced Toxicity in Brain Organoids

Obstetric Ultrasonography to Detect Fetal Abnormalities in a Mouse Model for Zika Virus Infection

Forebrain Neural Precursor Cells Are Differentially Vulnerable to Zika Virus Infection

Novel Non-Segmented Negative-Sense Rna Virus-Based Vaccine Platforms For Zika Virus

A zebrafish-based in vivo model of Zika virus infection unveils alterations of the glutamatergic neuronal development and NS4A as a key viral determinant of neuropathogenesis